Clinical Research Directory
Browse clinical research sites, groups, and studies.
4 clinical studies listed.
Filters:
Tundra lists 4 Bietti Crystalline Corneoretinal Dystrophy clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07653971
ZVS101e in Patients With Bietti's Crystalline Dystrophy
The goal of this clinical trial is to evaluate the safety and early effectiveness of ZVS101e in patients with Bietti crystalline dystrophy who meet the eligibility criteria for treatment under the translational application program in the Hainan Boao Lecheng International Medical Tourism Pilot Zone. Participants will: undergo screening and baseline assessments to confirm eligibility; receive a single subretinal injection of ZVS101e in the study eye; complete follow-up visits over 4 weeks after treatment for safety monitoring and assessment of early effectiveness.
Gender: All
Ages: 18 Years - Any
Updated: 2026-08-24
1 state
NCT06706427
Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy Subjects
The objective of this study is to evaluate the safety, tolerability, and efficacy of subretinal injection of NGGT001 in patients with Bietti Crystalline Corneoretinal Dystrophy (BCD) and to recommend the optimal dosage for future clinical administration.
Gender: All
Ages: 18 Years - Any
Updated: 2026-08-12
2 states
NCT06743646
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
This is a multi-center, randomized and controlled phase 3 clinical trial.
Gender: All
Ages: 18 Years - Any
Updated: 2026-06-17
8 states
NCT07307469
Compassionate Administration of ZVS101e for Extended Treatment
To provide treatment options for the control group of subjects who completed the 52-week follow-up of the Phase III clinical trial (Protocol number: ZYA-2024-001) of ZVS101e in subjects with Bietti crystalline corneoretinal dystrophy (BCD).
Gender: All
Ages: 18 Years - Any
Updated: 2026-06-17
5 states